Masters | Postgraduate Course - Cancer and Therapeutics PG Dip Course Details within Queen Mary University of London

Graduate Admissions Office
Tel:020 7882 5533
Fax:020 7882 5588
Email:admissions@qmul.ac.uk
Course Fees
Home and EU students 2018/19 Academic Year Full time £6,050 Part time £3,050 International students 2018/19 Academic Year<br /> Full time £14,600 Part time £7,350
Start Month(s)
September
Contact Name
Institute of Health Science Education
Tel
+44 (0)20 7882 2096
Cancer and Therapeutics PG Dip

Study Details

PGDip 9 months Full time 2 years Part time

This programme aims to provide you with a clear understanding of the scientific basis underlying the principles and practice of cancer therapeutics and the development, evaluation and implementation of new treatments. This is underpinned by a thorough knowledge of cancer biology and pathology, research methodologies, drug development and regulatory issues.

This programme will give you a comprehensive and holistic insight into the field of Cancer Therapeutics, covering all stages from the very basic cell and molecular biology underlying the development and pathogenesis of cancer as a disease, through pharmacology, drug development, novel therapeutics and cancer screening.

This programme will:

  • Give you a thorough grounding in the principles underlying cancer treatment
  • Introduce you to the regulatory framework underlying clinical research
  • Show you the steps involved in developing and implementing new treatments and how to apply this knowledge in your professional role
  • Encourage you to contribute to the research activity and knowledge base in improving cancer care.

Module details

Compulsory modules

  1. Cancer Biology
  2. Basic Pathology
  3. Cancer Prevention and Screening
  4. Genomic Approaches to Cancer
  5. Molecular Diagnostics and Therapeutics
  6. Molecular Pathology of Solid Tumours
  7. Research Methods
  8. Research Lab Skills

Option modules

  1. Biological Therapies
  2. Introduction to Bioinformatics
  3. Molecular Targeted Therapies and Immunotherapy for Blood Cancers

Entry Requirements

The programme is open to clinicians, graduate scientists, nurses, and other medical professionals working in a clinical, industrial or academic research environment. Entry to the programme requires a Bachelor’s degree in a relevant subject from a recognised institution with 2:1 or better or an appropriate professional qualification. Applicants with a 2:2 and strong supporting evidence will also be considered.

Programme Funding

There are a number of sources of funding available for Masters students.

These include a significant package of competitive Queen Mary University of London (QMUL) bursaries and scholarships in a range of subject areas, as well as external sources of funding.